Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,212

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,841

Class I recallsReasonable probability of serious health consequences

24,366

Class II recallsTemporary or medically reversible health consequences

2,892

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,073 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/frutas-y-hortalizas-del-sur-sa-expands-recalls-include-additional-lots-great-value-frozen-organicPublished October 2, 2026

Most affected stateHawaii 200 recalls mention this state

State: NJ ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 6, 2026 ET

Summary (Year to date)

1,714 recalls have been announced year to date.
Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (297).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,366
Class I	9,841
Class III	2,892
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,366
Class I	9,841
Class III	2,892
Not Yet Classified	2

FDA Recall Terminated Historical recordClass III

Duloxetine Delayed-release Capsules, USP, 60 mg, Rx Only, 1000 count bottle, Manufactured by: Laboratorios Dr. Esteve, S.A., Barcelona, Spain, Distributed by: Breckenridge Pharmaceutical, Inc., Boca Raton, FL 33487, NDC: 51991-748-10

by Breckenridge Pharmaceutical, Inc

Reason: Presence of Foreign Tablets/Capsules: one foreign capsule identified as omeprazole 10 mg was found in the bottle
Published: November 18, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

PGE 25mcg/ml, Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

PAPA/PGE1/PHENTO (35mg/12mcg/1.5mg/ml), Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

PAPA/PHENTO (15mg/0.8333mg/ml) Injection, 5 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

PGE 30mcg/ml Injection, 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

PAPA/PGE1/PHENTO (15mg/5mcg/0.5mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

PAPA/PGE1/PHENTO (30mg/40mcg/1mg/ml) Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

PAPA/PGE1/PHENTO (30mg/10mg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

PAPA/PGE1/PHENTO (22.5mg/8.33mcg/0.833mg/ml) Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

PAPA/PGE1/PHENTO (30mg/50mcg/0.5mg/ml), Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

PGE 20mcg/ml Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

PAPA/PHENTO (30mg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

PAPA+PGE1+PHENTO (30mg/20mcg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

Testosterone prop. 200 mg/ml Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

Testosterone Cypionate 250 mg/mL Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

Nandrolone 200 mg/ml Injection, 10 mL and 20 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

Stanozolol 200 mg/ml Injection, 20 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA

by Pacific Healthcare, Inc dba B&B Pharmacy

Reason: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Published: November 18, 2015
Distribution: CA and NJ

View recall →

FDA Recall Terminated Historical recordClass II

Doxycycline Hyclate Tablets, USP, 100 mg, 500-count bottle, Rx only, Distributed by: Truxton Inc. Bellmawr, NJ 08031, Manufactured for: Blu Caribe Dorado, PR 00646 USA, NDC 0463-6000-50 (top panel) NDC 24658-312-05 (side panel)

by C. O. Truxton

Reason: Labeling: Wrong Bar Code
Published: November 18, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Fenoglide (fenofibrate) tablets, 120 mg Tablets, 90 Ct Bottle, Rx Only. Distributed by: Santarus, Inc. San Diego, CA 92130. NDC: 68012-495-90.

by Valeant Pharmaceuticals North America LLC

Reason: Failed Dissolution Specifications: Failed 24 month dissolution testing.
Published: November 11, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

RANITIDINE SYRUP (RANITIDINE ORAL SOLUTION, USP) 15 mg/mL (75 mg/5 mL), 473 mL (16 fl oz), Rx only. Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC: 0603-9418-58.

by Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals

Reason: Failed Stability Specifications: Out of Specification results obtained for preservative butylparaben.
Published: November 11, 2015
Distribution: Nationwide

View recall →

Data last updated: October 6, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.